Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
TLC doses first patients in Phase I/II study of TLC590 Taiwan Liposome Company (TLC) has dosed the first patients in a Phase I/II trial to... 15th August 2018